Triazolopyridine compounds and methods for the treatment of cystic fibrosis
申请人:Flatley Discovery Lab, LLC
公开号:US10472357B2
公开(公告)日:2019-11-12
The invention relates to a compound of Formula I or IA and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I or IA to a patient in need thereof:
本发明涉及一种式 I 或 IA 的化合物和治疗囊性纤维化的方法,包括向有需要的患者施用治疗有效量的式 I 或 IA 化合物的步骤:
Zorin, V. V.; Germash, A. V.; Nikolaeva, S. V., Journal of Organic Chemistry USSR (English Translation), 1984, vol. 20, p. 1802 - 1804
作者:Zorin, V. V.、Germash, A. V.、Nikolaeva, S. V.、Kirillov, I. T.、Zlot-skii, S. S.、et al.
DOI:——
日期:——
ZORIN, V. V.;GERMASH, A. V.;NIKOLAEVA, S. V.;KIRILLOV, I. T.;ZLOTSKIJ, S.+, ZH. ORGAN. XIMII, 1984, 20, N 9, 1974-1976
作者:ZORIN, V. V.、GERMASH, A. V.、NIKOLAEVA, S. V.、KIRILLOV, I. T.、ZLOTSKIJ, S.+